Facilitator Title
Ken Shadlen Secondary patents, Life-Cycle Management, and Ever-Greening: India in Comparative Perspective
Tessel Mellema How TTIP can damage access to affordable medicines in the European Union
Christian Wagner Alfs Our toolbox: Beyond SRL
Harry Thangaraj Socially Responsible Licensing: Bringing the Public Interest Back into University Tech Transfer”
Joe McArthur Open Access, Open Science and Open Innovation – a fix to the drug problem?
Celine Grillon Sofosbuvir patent opposition in Europe
Jamie Love Landscaping De-linkage
Chas Bountra Society desperately needs more affordable medicines. How can we meet this expectation?
Sarah Chan Genes, Cells and Medicines: Private rights or public goods?
Hans Ebbers Utrecht Centre of Excellence of Affordable Biotherapeutics for Public Health (UCAB)
Katerina Sideri Reflections on good patent governance

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s